Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06903962 · ClinicalTrials.gov registry record · NA

Mind Body Intervention for Chronic Upper Extremity Pain (Repetitive Stress Injury)

A NA study of Chronic Pain and Chronic Pain Syndrome, sponsored by Beth Israel Deaconess Medical Center.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06903962: Recruiting NA study of Chronic Pain and Chronic Pain Syndrome, sponsored by Beth Israel Deaconess Medical Center.

NCT06903962 is a NA study of Chronic Pain and Chronic Pain Syndrome that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 40 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06903962, a NA study of Chronic Pain and Chronic Pain Syndrome, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The goal of this nonrandomized pilot study is to test a mind-body interventional approach for the treatment of chronic upper extremity pain or repetitive stress injury of the upper extremity (wrist/shoulder/elbow). 1. To determine if a mind-body intervention improves upper extremity functional capacity (ie., Disability of Arm Shoulder Hand - DASH) among people with chronic wrist, elbow, and shoulder pain 2. To determine if a mind-body intervention decreases pain intensity, pain-related anxiety, and overall somatic complaints in our trial participants. 3. To tailor the intervention and the outcomes assessment procedures for conducting a trial in a population with upper extremity pain.

Primary Outcome

The DASH is a commonly used and validated 38 question survey self-report survey assessing the effects of upper extremity disabling conditions on functional activity, pain, sleep, and other parameters

Interventions

  • BEHAVIORAL Mind-Body Intervention

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-03-28
Est. Completion 2027-06-01
Phase NA

What NCT06903962 shows while recruiting

NCT06903962 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (95% lower).

The record links to 3 conditions, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Mind-Body Intervention is the first listed.

NCT06903962 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06903962 about?

NCT06903962 is a clinical study titled "Mind Body Intervention for Chronic Upper Extremity Pain (Repetitive Stress Injury)". The goal of this nonrandomized pilot study is to test a mind-body interventional approach for the treatment of chronic upper extremity pain or repetitive stress injury of the upper extremity (wrist/shoulder/elbow). 1. To determine if a mind-body intervention improves upper extremity functional capa...

What is the current status of trial NCT06903962?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-03-28. Estimated completion is 2027-06-01.

What conditions does trial NCT06903962 study?

This clinical trial studies the following conditions: Chronic Pain, Chronic Pain Syndrome, Repetitive Stress Injury.

What interventions are being tested in trial NCT06903962?

The interventions under investigation include: Mind-Body Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06903962?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06903962 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06903962's enrollment target sits among peer trials

40 214th of 301 higher than 81 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06903962, the US trial registry maintained by the National Library of Medicine. NCT06903962 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.